DeNovix Inc. announces the release of CellGlow, a new ready-to-use viability assay for automated cell counting.
Ultra-weak ‘biophotons’ might be used to diagnose disease, or could even represent a new signalling mechanism in cells.
This postdoctoral researcher explores biomarkers and the tumor microenvironment. She hopes to develop therapeutic strategies to combat colorectal cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results